Research area
Phase 1 Prostate Cancer trials
Prostate cancer studies test investigational medications, imaging methods, and monitoring approaches at different stages of the disease. At Phase 1 Cancer Trials, we can help you find out whether one of these studies may be a fit for you.
Updated
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Phase 1 prostate cancer studies in numbers
- Phase 1 prostate cancer studies recruiting in the U.S.
- 161
- states with a study site
- 41
- studies that accept healthy volunteers
- 1
Source: ClinicalTrials.gov. Data processed .
Find Phase 1 prostate cancer studies by state
These states have the most studies recruiting right now.
California
43 studies recruiting.
Texas
37 studies recruiting.
New York
33 studies recruiting.
Florida
28 studies recruiting.
Pennsylvania
19 studies recruiting.
Michigan
18 studies recruiting.
Phase 1 prostate cancer studies recruiting now
As of November 17, 2026, 161 Phase 1 prostate cancer studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry. This is what they have in common.
What they test
- medications142
- procedures18
- biologics such as vaccines or antibodies14
- radiation8
- other approaches6
A study can test more than one.
Main purpose
- treating a condition140
- diagnosis13
- basic science2
- other purposes2
Phase
- Early Phase 114
- Phase 181
- Phase 1/266
Who runs them
- industry105
- university, hospital or other54
- government2
Who they enroll
- adults (18 to 64)161
- older adults (65 and over)161
- children (under 18)1
1 also accept healthy volunteers.
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 161 studies.
Recently updated Phase 1 prostate cancer studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Astellas Pharma Global Development, Inc.
- Recruiting in
- Duarte, CA · Fairfax, VA · Houston, TX · and 6 more U.S. locations
- Registry record
- NCT05997615 · updated
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
- Phase 1/2
- Ages 18 to 120
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda, MD
- Registry record
- NCT07667400 · updated
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- Novartis Pharmaceuticals
- Recruiting in
- Birmingham, AL · Charleston, SC · Durham, NC · and 5 more U.S. locations
- Registry record
- NCT07190300 · updated
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Amgen
- Recruiting in
- Atlanta, GA · Cincinnati, OH · Denver, CO · and 15 more U.S. locations
- Registry record
- NCT04221542 · updated
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- University of California, San Francisco
- Recruiting in
- San Francisco, CA
- Registry record
- NCT07145177 · updated
RYZ711 Diagnostic Platform Study
- Phase 1/2
- Ages 18 and older
- Male participants
- Sponsor
- RayzeBio, Inc.
- Recruiting in
- Omaha, NE
- Registry record
- NCT07862582 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in the United States on ClinicalTrials.gov.
What prostate cancer studies look at
Each prostate cancer study is built to answer a single, specific question. Because of that, the things asked of you in one study will not match what another asks. Across the different stages of the disease, studies evaluate ways of imaging, approaches to monitoring, and medications that are still investigational.
Investigational is the word for whatever a study is testing. It means the learning is not finished. Researchers do not yet know in full how well it performs or which risks it carries, and that gap in knowledge is exactly why the study is being run.
Who may be able to take part
Each study comes with requirements of its own. A study may look at your age, your medical background, whatever medications you are on at present, and the effect prostate cancer has on you. People without the condition are also enrolled in some studies.
We do not expect you to judge for yourself whether you fit. That check belongs to the study team, and it happens when you come in for a screening visit. Our guide to eligibility and screening explains the process.
What taking part usually involves
A first conversation
The first step is a conversation. You hear a broad outline of the study from a coordinator, and your questions are answered then, ahead of every other step.
Informed consent
Consent is your decision. The study team hands you a written document that sets out everything about the study, the risks known so far among them, and agreeing or not is up to you.
Screening
Screening does not always end in enrollment. The team uses tests and questions about your health to find out if this particular study fits you, and for some people the answer is no.
Study visits
Taking part in a Phase 1 trial means coming to planned appointments, and the study team uses each one to check on how you are doing. You are free to withdraw whenever you choose.
Questions about Phase 1 prostate cancer studies
Do I need a diagnosis to join a study about prostate cancer?
The answer varies from one Phase 1 cancer trial to the next. A confirmed diagnosis is required by some, while others assess you as part of screening. The study team will explain which applies to you.
Would I have to change the care I receive now?
A change to your care is not something to make by yourself. Whether current care can carry on alongside a study differs: some studies permit it, others do not. This is a point the study doctor will review with you. Before you reach a decision, you are also welcome to raise it with the doctor who already looks after you.
Is there a cost to take part?
As a general rule, participants pay nothing for the visits, tests, and medication that are part of a study. Find out more about costs.
Ask about Phase 1 prostate cancer studies
Getting in touch places you under no obligation. Give us a little information about yourself, and a coordinator will then reach out to you.
Independent information
- Prostate Cancer — National Cancer Institute (NIH)
- What Are Clinical Trials? — National Cancer Institute (NIH)
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)